Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway - PubMed (original) (raw)

. 2015 Sep 15;137(6):1258-68.

doi: 10.1002/ijc.29488. Epub 2015 Mar 13.

Shinichi Kanno 1, Katsuhiko Nosho 1, Yasutaka Sukawa 2, Kei Mitsuhashi 1, Hiroyoshi Kurihara 1, Hisayoshi Igarashi 1, Taiga Takahashi 1, Mami Tachibana 1, Hiroaki Takahashi 3, Shinji Yoshii 4, Toshinao Takenouchi 5, Tadashi Hasegawa 6, Kenji Okita 7, Koichi Hirata 7, Reo Maruyama 8, Hiromu Suzuki 8, Kohzoh Imai 9, Hiroyuki Yamamoto 10, Yasuhisa Shinomura 1

Affiliations

• PMID: 25703934
• DOI: 10.1002/ijc.29488

Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway

Miki Ito et al. Int J Cancer. 2015.

Abstract

Human gut microbiota is being increasingly recognized as a player in colorectal cancers (CRCs). Evidence suggests that Fusobacterium nucleatum (F. nucleatum) may contribute to disease progression and is associated with CpG island methylator phenotype (CIMP) and microsatellite instability (MSI) in CRCs; however, to date, there are no reports about the relationship between F. nucleatum and molecular features in the early stage of colorectal tumorigenesis. Therefore, we investigated the presence of F. nucleatum in premalignant colorectal lesions. In total, 465 premalignant lesions (343 serrated lesions and 122 non-serrated adenomas) and 511 CRCs were studied. We determined the presence of F. nucleatum and analyzed its association with molecular features including CIMP, MSI and microRNA-31 status. F. nucleatum was detected in 24% of hyperplastic polyps, 35% of sessile serrated adenomas (SSAs), 30% of traditional serrated adenomas (TSAs) and 33% of non-serrated adenomas. F. nucleatum was more frequently detected in CIMP-high premalignant lesions than in CIMP-low/zero lesions (p = 0.0023). In SSAs, F. nucleatum positivity increased gradually from sigmoid colon to cecum (p = 0.042). F. nucleatum positivity was significantly higher in CRCs (56%) than in premalignant lesions of any histological type (p < 0.0001). In conclusion, F. nucleatum was identified in premalignant colorectal lesions regardless of histopathology but was more frequently associated with CIMP-high lesions. Moreover, F. nucleatum positivity increased according to histological grade, suggesting that it may contribute to the progression of colorectal neoplasia. Our data also indicate that F. nucleatum positivity in SSAs may support the "colorectal continuum" concept.

Keywords: BRAF; Fusobacterium; KRAS; MLH1; colon polyp; colorectum; dysplasia; miR-31; microbiome; serrated neoplasia pathway.

© 2015 UICC.

PubMed Disclaimer

Similar articles

• MicroRNA-31 expression in relation to BRAF mutation, CpG island methylation and colorectal continuum in serrated lesions.
  Ito M, Mitsuhashi K, Igarashi H, Nosho K, Naito T, Yoshii S, Takahashi H, Fujita M, Sukawa Y, Yamamoto E, Takahashi T, Adachi Y, Nojima M, Sasaki Y, Tokino T, Baba Y, Maruyama R, Suzuki H, Imai K, Yamamoto H, Shinomura Y. Ito M, et al. Int J Cancer. 2014 Dec 1;135(11):2507-15. doi: 10.1002/ijc.28920. Epub 2014 Apr 30. Int J Cancer. 2014. PMID: 24752710
• Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
  Nosho K, Sukawa Y, Adachi Y, Ito M, Mitsuhashi K, Kurihara H, Kanno S, Yamamoto I, Ishigami K, Igarashi H, Maruyama R, Imai K, Yamamoto H, Shinomura Y. Nosho K, et al. World J Gastroenterol. 2016 Jan 14;22(2):557-66. doi: 10.3748/wjg.v22.i2.557. World J Gastroenterol. 2016. PMID: 26811607 Free PMC article. Review.
• Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
  Kim JH, Bae JM, Cho NY, Kang GH. Kim JH, et al. Oncotarget. 2016 Mar 22;7(12):14095-111. doi: 10.18632/oncotarget.7374. Oncotarget. 2016. PMID: 26883113 Free PMC article.
• Fusobacterium's link to colorectal neoplasia sequenced: A systematic review and future insights.
  Hussan H, Clinton SK, Roberts K, Bailey MT. Hussan H, et al. World J Gastroenterol. 2017 Dec 28;23(48):8626-8650. doi: 10.3748/wjg.v23.i48.8626. World J Gastroenterol. 2017. PMID: 29358871 Free PMC article. Review.
• NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
  Kim JH, Hong JH, Choi YL, Lee JA, Seo MK, Lee MS, An SB, Sung MJ, Cho NY, Kim SS, Shin YK, Kim S, Kang GH. Kim JH, et al. J Pathol. 2021 Dec;255(4):399-411. doi: 10.1002/path.5779. Epub 2021 Sep 23. J Pathol. 2021. PMID: 34402529

Cited by

• Fusobacterium nucleatum Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation.
  Engevik MA, Danhof HA, Ruan W, Engevik AC, Chang-Graham AL, Engevik KA, Shi Z, Zhao Y, Brand CK, Krystofiak ES, Venable S, Liu X, Hirschi KD, Hyser JM, Spinler JK, Britton RA, Versalovic J. Engevik MA, et al. mBio. 2021 Mar 2;12(2):e02706-20. doi: 10.1128/mBio.02706-20. mBio. 2021. PMID: 33653893 Free PMC article.
• Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer.
  Zhang S, Kong C, Yang Y, Cai S, Li X, Cai G, Ma Y. Zhang S, et al. Theranostics. 2020 Sep 18;10(25):11595-11606. doi: 10.7150/thno.49515. eCollection 2020. Theranostics. 2020. PMID: 33052235 Free PMC article.
• The cancer chemotherapeutic 5-fluorouracil is a potent Fusobacterium nucleatum inhibitor and its activity is modified by intratumoral microbiota.
  LaCourse KD, Zepeda-Rivera M, Kempchinsky AG, Baryiames A, Minot SS, Johnston CD, Bullman S. LaCourse KD, et al. Cell Rep. 2022 Nov 15;41(7):111625. doi: 10.1016/j.celrep.2022.111625. Cell Rep. 2022. PMID: 36384132 Free PMC article.
• Exploring the interplay between Fusobacterium nucleatum with the expression of microRNA, and inflammatory mediators in colorectal cancer.
  Bostanghadiri N, Razavi S, Shariati A, Talebi M, Mirkalantari S, Emami Razavi A, Darban-Sarokhalil D. Bostanghadiri N, et al. Front Microbiol. 2023 Nov 23;14:1302719. doi: 10.3389/fmicb.2023.1302719. eCollection 2023. Front Microbiol. 2023. PMID: 38075864 Free PMC article.
• The Four Horsemen in Colon Cancer.
  Hernández-Luna MA, López-Briones S, Luria-Pérez R. Hernández-Luna MA, et al. J Oncol. 2019 Sep 29;2019:5636272. doi: 10.1155/2019/5636272. eCollection 2019. J Oncol. 2019. PMID: 31662752 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal